Cargando…
Modulating serine palmitoyltransferase‐deoxysphingolipid axis in cancer therapy
A schematic illustration is given regarding serine restriction on tumor growth. Once the cellular abundance of serine decreased or alanine accumulated, the serine palmitoyltransferase (SPT) alternatively conjugates alanine and palmitoyl‐CoA to form 3‐keto‐intermediates, which is rapidly converted to...
Autores principales: | Xiang, Yuancai, Zhao, Kun, Tang, Yi‐Quan, Dai, Rongyang, Miao, Hongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491209/ https://www.ncbi.nlm.nih.gov/pubmed/34766138 http://dx.doi.org/10.1002/mco2.44 |
Ejemplares similares
-
SERIneALanine Killer: SPT promiscuity inhibits tumour growth via intra-tumoral deoxysphingolipid production
por: Falcone, Mattia, et al.
Publicado: (2020) -
Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023) -
Ketogenic diet: new avenues to overcome colorectal cancer
por: Xiang, Yuancai, et al.
Publicado: (2022) -
Targeting metabolic/epigenetic pathways: a potential strategy for cancer therapy in diffuse intrinsic pontine gliomas
por: Zhao, Kun, et al.
Publicado: (2020) -
Serine palmitoyltransferase assembles at ER–mitochondria contact sites
por: Aaltonen, Mari J, et al.
Publicado: (2021)